1[1] Carter CL,Allen C,Henson DE.Relation of tumor size,lymph node sta tus,and survival in 24,740 breast cancer casas.Cancer,1989,63∶181-187
2[2] Fisher B,Costantino JP,Wickerham DL,et al.Tamoxifen for preventio n of breast cancer:Report of the National Surgical Adjuvant Breast and Bowel Pro ject P-1 Study.J Natl Cancer Inst,1998,90∶1371-1388
3[3] Schnitt SJ,Connolly JL,Harris JR,et al.Pathologic predictors of e a rly local recurrences in stage Ⅰ and Ⅱ breast cancer treated by primary radiat ion therapy.Cancer,1984,53∶1049-1057
4[4] Guidi AJ,Connolly JL,Harris JR,et al.The relationship between sha ved margin and ink margin status in breast excision specimens.Cancer,1997,79∶15 68-1573
5[5] Rosai J.Borderline epithelial lesions of the breast.Am J Surg Pat hol,1991,15∶209-221
6[6] Page DL,Stell CM,Dixon JM,et al.Carcinoma in situ and patients at high risk of breast cancer.BMJ,1995,42∶310-319
7[7] NCCN practice guidelines for the treatment of breast cancer.Oncol ogy,1999,13∶No:11A
8[8] Hansen S,Graban DA,Sorenser FB,et al.The prognostic value of angi ogenesis by chalkley counting in a confirmatory study design on 836 breast cance r patients.Clinical Cancer Research,2000,6∶139-146
9[9] Weaver DL,Krag DN,Ashikaga T,et al.Pathologic analysis of sentine l and nonsentinel lymph nodes in breast carcinoma:A multicerter study.Cancer,20 00,88(5)∶1099-1107
